Prostate cancer: A very common cancer in men
Thursday, September 25th, 2008 Posted in prostate cancer | No Comments »Prostate cancer is a common cancer for men, second only to skin cancer. The American Cancer Society estimates that approximately 186,000 men will be diagnosed with prostate cancer in 2008. Prostate cancer accounts for about 9 percent of cancer-related deaths in ...
Prostate cancer hormone therapy may raise mortality in erderly
Wednesday, September 24th, 2008 Posted in hormone therapy | No Comments »In elderly men with early-stage prostate cancer, receiving hormone therapy is associated with an increase in all-cause mortality, according to a study reported Tuesday at the American Society for Therapeutic Radiology and Oncology's 50th Annual Meeting underway in Boston. It's currently ...
Hormone Therapy Not Best for Older Prostate Cancer Patients
Wednesday, September 24th, 2008 Posted in hormone therapy | No Comments »Older men with early-stage prostate cancer who are given hormone therapy before radiation seed implant therapy face a 20 percent greater risk of dying than those who get radiation treatment alone, new research suggests. Focusing on men over the age of ...
When/if to start hormones for prostate cancer patients whose PSA rises after radiation
Tuesday, September 23rd, 2008 Posted in hormone therapy, radiation therapy | No Comments »A new Fox Chase Cancer Center study suggests men with early stage prostate cancer treated with radiation therapy should begin hormone therapy immediately if their PSA level rises quickly and doubles within six months at any time after treatment. The ...
Fosamax Drug Can Slow Bone Loss in Prostate Cancer Patients
Sunday, September 21st, 2008 Posted in hormone therapy | No Comments »Men receiving hormone-deprivation therapy for advanced but localized prostate cancer can develop bone loss as a side effect of the treatment. But a new study finds that bone-strengthening drugs such as Fosamax (generic name alendronate) can help prevent that damage. Having earlier ...
Hormone Ablation Therapy (Including Intermittent) In Patients With Prostate Cancer
Sunday, September 21st, 2008 Posted in hormone therapy | No Comments »Dr. Kurt Miller, Professor of Urology at Univsitätsmedizin, Berlin, presented the use of androgen deprivation therapy in patients with prostate cancer. He presented the results of a randomized prospective trial, (AU0 AP 17/95), comparing intermittent and continuous androgen suppression in ...
September - prostate cancer awareness month
Saturday, September 20th, 2008 Posted in prostate related | No Comments »During this important month and throughout the year, the AUA can provide information, statistics and expert commentary on subjects related to prostate health. The AUA can assist in developing related story topics on prostate health, such as: -- New risk factors ...
Cholesterol Harms More Than The Heart: Prostate Also At Risk
Saturday, September 20th, 2008 Posted in prostate cancer risks | No Comments »Heart health isn't the only reason to pay attention to cholesterol levels. Recent research has shown that cholesterol plays an important role in prostate health as well. September has been designated both National Prostate Health Month and National Cholesterol Education Month, ...
Focal prostate cancer therapy utilizing cryosurgery and hifu
Saturday, September 20th, 2008 Posted in hifu, prostate cancer, prostate cryotherapy | No Comments »Prostate-Sparing Targeted Therapies (Cryotherapy And HIFU) were reviewed by Dr. Ivan Colon, Assistant Professor of Urology, SUNY Downstate Medical School, and the use of HIFU for this indication was discussed by Dr. Ivan Grunberger, Associate Clinical Professor of Urology SUNY ...
Prostate cancer genes behave like those in embryo
Wednesday, September 17th, 2008 Posted in prostate related | No Comments »Genes activity in prostate cancer is reminiscent of that in the developing fetal prostate, providing further evidence that all cancers are not equal, Johns Hopkins researchers report. The finding could help scientists investigate how to manipulate the genetic program to ...